HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.

Abstract
Aberrant activation of the TAL1 is associated with up to 60% of T-ALL cases and is involved in CTCF-mediated genome organization within the TAL1 locus, suggesting that CTCF boundary plays a pathogenic role in T-ALL. Here, we show that -31-Kb CTCF binding site (-31CBS) serves as chromatin boundary that defines topologically associating domain (TAD) and enhancer/promoter interaction required for TAL1 activation. Deleted or inverted -31CBS impairs TAL1 expression in a context-dependent manner. Deletion of -31CBS reduces chromatin accessibility and blocks long-range interaction between the +51 erythroid enhancer and TAL1 promoter-1 leading to inhibition of TAL1 expression in erythroid cells, but not T-ALL cells. However, in TAL1-expressing T-ALL cells, the leukemia-prone TAL1 promoter-IV specifically interacts with the +19 stem cell enhancer located 19 Kb downstream of TAL1 and this interaction is disrupted by the -31CBS inversion in T-ALL cells. Inversion of -31CBS in Jurkat cells alters chromatin accessibility, histone modifications and CTCF-mediated TAD leading to inhibition of TAL1 expression and TAL1-driven leukemogenesis. Thus, our data reveal that -31CBS acts as critical regulator to define +19-enhancer and the leukemic prone promoter IV interaction for TAL1 activation in T-ALL. Manipulation of CTCF boundary can alter TAL1 TAD and oncogenic transcription networks in leukemogenesis.
AuthorsYing Li, Ziwei Liao, Huacheng Luo, Aissa Benyoucef, Yuanyuan Kang, Qian Lai, Sinisa Dovat, Barbara Miller, Iouri Chepelev, Yangqiu Li, Keji Zhao, Marjorie Brand, Suming Huang
JournalNucleic acids research (Nucleic Acids Res) Vol. 48 Issue 6 Pg. 3119-3133 (04 06 2020) ISSN: 1362-4962 [Electronic] England
PMID32086528 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.
Chemical References
  • CCCTC-Binding Factor
  • CTCF protein, human
  • Chromatin
  • DNA-Binding Proteins
  • T-Cell Acute Lymphocytic Leukemia Protein 1
  • TAL1 protein, human
Topics
  • Binding Sites (genetics)
  • CCCTC-Binding Factor (genetics)
  • Carcinogenesis (genetics)
  • Chromatin (genetics)
  • DNA-Binding Proteins (genetics)
  • Enhancer Elements, Genetic (genetics)
  • Gene Expression Regulation, Neoplastic
  • Genome, Human (genetics)
  • Histone Code (genetics)
  • Humans
  • Jurkat Cells
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (genetics, pathology)
  • Protein Binding (genetics)
  • T-Cell Acute Lymphocytic Leukemia Protein 1 (genetics)
  • Transcription, Genetic (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: